Company intelligence / Profile preview

Ingenius Biotech

Miami, Florida, United States

Ownership: Private
Development stage: Other

Overview

InGenius Biotech is a healthcare technology and biotechnology company focused on the field of pharmacogenomics and personalized medicine. The company provides genetic testing services and clinical decision support tools designed to help healthcare providers optimize medication selection and dosing based on a patient's unique genetic profile. By identifying how individuals metabolize specific drugs, InGenius aims to reduce adverse drug reactions and improve therapeutic efficacy across various medical specialties. Their primary offerings include comprehensive pharmacogenomic (PGx) panels and a proprietary software platform that integrates genetic data into clinical workflows.

Therapeutic areas: Other
Modalities: Diagnostic testGenetic testing
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Ingenius Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ingenius Biotech.

Explore the full profile